Product Information

ROPINIROLE HCL 5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0832 per EA under NDC 43547027410. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 5, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL 5 MG TABLET

ropinirole hydrochloride
$0.0832per EA

Strength

5 mg/1

NDC

43547027410

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078110

FDA Approved

5/5/2008

TE Code

AB

On Market Since

9/20/2011

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0832 per EA
All-time high$0.1424 (Jan 15, 2014)
All-time low$0.0672 (Jan 22, 2025)
52-week high$0.0889
52-week low$0.0748
Median price$0.1096
Average price$0.1077
Largest weekly change+51.8% (Dec 20, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.6%

1M

+2.6%

3M

+11.2%

6M

+7.2%

1Y

-6.4%

3Y

-21.1%

5Y

-27.0%

All

-30.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0832 per EA (NDC 43547027410), effective Aug 19, 2026.

How has the price of ROPINIROLE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL 5 MG TABLET has declined 30.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for ROPINIROLE HCL 5 MG TABLET has ranged from a low of $0.0672 (Jan 22, 2025) to a high of $0.1424 (Jan 15, 2014), with a median of $0.1096 per EA.

Are there cheaper alternatives to ROPINIROLE HCL 5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ROPINIROLE HCL 5 MG TABLET?

ROPINIROLE HCL 5 MG TABLET (NDC 43547027410) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.